- Home
- ERAS vs ASIX Comparison
ERAS vs ASIX Comparison
Compare ERAS & ASIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- ASIX
- Stock Information
- Founded
- ERAS 2018
- ASIX 2016
- Country
- ERAS United States
- ASIX United States
- Employees
- ERAS N/A
- ASIX N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- ASIX Major Chemicals
- Sector
- ERAS Health Care
- ASIX Industrials
- Exchange
- ERAS Nasdaq
- ASIX Nasdaq
- Market Cap
- ERAS 439.7M
- ASIX 526.1M
- IPO Year
- ERAS 2021
- ASIX N/A
- Fundamental
- Price
- ERAS $2.86
- ASIX $14.31
- Analyst Decision
- ERAS Buy
- ASIX Buy
- Analyst Count
- ERAS 6
- ASIX 1
- Target Price
- ERAS $3.50
- ASIX $32.00
- AVG Volume (30 Days)
- ERAS 1.3M
- ASIX 367.1K
- Earning Date
- ERAS 11-12-2025
- ASIX 11-07-2025
- Dividend Yield
- ERAS N/A
- ASIX 4.44%
- EPS Growth
- ERAS N/A
- ASIX 35.47
- EPS
- ERAS N/A
- ASIX 1.92
- Revenue
- ERAS N/A
- ASIX $1,491,348,000.00
- Revenue This Year
- ERAS N/A
- ASIX $4.71
- Revenue Next Year
- ERAS N/A
- ASIX $4.59
- P/E Ratio
- ERAS N/A
- ASIX $7.51
- Revenue Growth
- ERAS N/A
- ASIX N/A
- 52 Week Low
- ERAS $1.01
- ASIX $14.10
- 52 Week High
- ERAS $3.30
- ASIX $33.00
- Technical
- Relative Strength Index (RSI)
- ERAS 69.19
- ASIX 22.77
- Support Level
- ERAS $2.21
- ASIX $14.80
- Resistance Level
- ERAS $2.90
- ASIX $16.79
- Average True Range (ATR)
- ERAS 0.20
- ASIX 0.83
- MACD
- ERAS 0.04
- ASIX -0.35
- Stochastic Oscillator
- ERAS 96.19
- ASIX 3.82
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About ASIX AdvanSix Inc.
AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.